Evaluating HIV vaccines using nonhuman primates
Official title: Simian Vaccine Evaluation Unit: Maintenance of Nonhuman Primates
Funded at University of Louisiana at Lafayette · NIH-10577408 · Data updated 2026-11-12
This study is looking at how well new HIV vaccines and prevention methods work using nonhuman primates, with the goal of finding effective ways to stop or manage HIV infection.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Louisiana at Lafayette NIH-funded |
| Lab location | 1 site (Lafayette, United States) |
| Project start | April 1, 2020 |
| Project end | March 31, 2027 |
| Funding year | 2022 |
| Award (this year) | $148,688 |
| NIH project number | 75N93020D00008-P00002-759302000002-1 |
| Project ID | NIH-10577408 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at high risk for HIV infection who may benefit from new prevention strategies.
✕Less likely to help
Patients who are already living with HIV or those who do not have a risk of exposure to the virus may not receive direct benefits from this research.
What this research studies
This research focuses on the use of nonhuman primates (NHPs) to evaluate candidate HIV vaccines and prevention strategies. The Simian Vaccine Evaluation Units (SVEUs) provide essential resources for conducting preclinical studies, allowing researchers to assess immune responses and vaccine efficacy. By maintaining a breeding colony and ensuring proper housing and care for the NHPs, the program supports various stages of AIDS vaccine research, ultimately aiming to identify effective vaccines that can prevent or control HIV infection.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective HIV vaccines that significantly reduce the risk of infection in humans.
How similar studies have gone: Previous research using nonhuman primates for vaccine evaluation has shown promise, indicating that this approach is a well-established method in the field.
Where this research is happening
-
University of Louisiana at Lafayette
Lafayette, United States Active
Researchers
- Principal investigator: Villinger, Francois — University of Louisiana at Lafayette
- Study coordinator: Villinger, Francois
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.